Ravi Worldwide Medicines Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 7 Year, 2 Months
About Ravi Worldwide Medicines
The Company is engaged in the Trading Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Thangavel Ranjith and Mummachi Thangavel serve as directors at the Company.
- CIN/LLPIN
U51909DL2017PTC325841
- Company No.
325841
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2017
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ravi Worldwide Medicines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thangavel Ranjith  | Director | 09-Nov-2017 | Current |
| Mummachi Thangavel | Director | 09-Nov-2017 | Current |
Financial Performance of Ravi Worldwide Medicines.
Enhance accessibility to Ravi Worldwide Medicines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ravi Worldwide Medicines?
Unlock access to Ravi Worldwide Medicines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Trichy-Ravi Remedy Drugs Private LimitedActive 7 years 3 monthsThangavel Ranjith and Mummachi Thangavel are mutual person
Kolkata-Ravi Specialities Pharma Private LimitedActive 6 yearsThangavel Ranjith and Mummachi Thangavel are mutual person
Imphal-Ravispecialitiespharma Private LimitedActive 6 years 11 monthsThangavel Ranjith and Mummachi Thangavel are mutual person
- Trichy-Ravi Speed Parcel Services Private LimitedActive 7 years 1 month
Thangavel Ranjith and Mummachi Thangavel are mutual person
- Trichy-Ravi Consumer Care Private LimitedActive 7 years 3 months
Thangavel Ranjith and Mummachi Thangavel are mutual person
- Rsp-Ravi Specialities Pharma (Opc) Private LimitedActive 7 years 9 months
Thangavel Ranjith is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ravi Worldwide Medicines?
Unlock and access historical data on people associated with Ravi Worldwide Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ravi Worldwide Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravi Worldwide Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.